Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)

Summary

This is a single-arm study to evaluate safety and tolerability of oral IW-6463 in adults diagnosed with MELAS.

Timeline

Start

2020-11-13

Primary completion

2022-01-23

Completion

2022-01-23

Outcome

Outcome not reported

Stopped (Enrollment): “Study terminated due to enrollment challenges.”

Drugs

Indications